Medicare Prescription Drug Price Negotiation Act of 2019
Official title: To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate covered part D drug prices on behalf of Medicare beneficiaries.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Subcommittee Hearings Held.
Medicare Prescription Drug Price Negotiation Act of 2019
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-275/
"H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-275/.
H.R. 275, 116th Cong. (2026), https://openamerica.io/bill/116-HR-275/.
[H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019](https://openamerica.io/bill/116-HR-275/)